MIOS - HRA is a medical office offering high level ophthalmic services in both comprehensive ophthalmology and specialized care in retinal diseases (medical and surgical) and all aspects of ocular inflammation. Its director, professor Marc de Smet obtained his medical degree in Canada. He is board certified in Canada, the United States, and Europe. He is a fellow of the Royal College of Surgeons of Canada, Royal College of Ophthalmologists of the UK, the Association for Research in Vision and Ophthalmology. He has an international reputation in the medical and surgical treatments of retinal diseases and uveitis. He has received several international awards for his contributions and innovations and was elected to the Retinal Hall of Fame in 2022. Ongoing collaborations maintain close ties with many world renowned centers. The team includes board certified optometrists, ophthalmologists which allows us to cover also general ophthalmology, optometric exams, refractions and glasses prescription, contact lenses and night lenses, myopia management of children and adolescents). Minor procedures including injections are performed in the office, more involved surgery in one of several local clinics chosen according to the operation and need of the patient. More information available at: http://www.retina-uveitis.ch/

">

Swiss Eye Centre for Ophthalmology and Glaucoma is a specialised ophthalmology centre, dedicated to the management of patients with eye disorders and more specifically glaucoma and cataracts. Our mission is to improve the vision and quality of life of our patients by putting together three fundamental pillars of medicine: specialised care, research and teaching. Our independent practice is committed to innovation and excellence in ophthalmic surgery and the management of glaucoma and cataracts. Our main objective is to develop and perfect the treatments offered as well as the surgical and laser techniques.

Hirslanden is committed to high-quality, responsible and efficiently integrated healthcare that focuses on the needs of the individual. Working together with private and public cooperation partners, the Hirslanden Group prioritises ongoing development of the Continuum of Care concept. From birth to old age, from prevention to healing, Hirslanden is always there, both on a physical and digital level. Hirslanden differentiates itself from the rest of the market as a service provider with first-class medical and service quality, which is guaranteed by highly qualified independent specialists with years of experience who offer excellent care and services. Interdisciplinary medical centres of expertise, specialised institutes and competent cooperation partners enable optimal, personalised diagnosis and treatment, regardless of case complexity, in both inpatient and outpatient contexts. The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 5 outpatient surgery centres, 18 radiology and 6 radiotherapy institutes. The Group has 2,515 partner doctors and 11,025 employees, 551 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2021/22 financial year, the Group generated turnover of CHF 1,885 million. As at 31 March 2022, the Group had treated 109,624 patients for a total of 472,301 inpatient days. The patient mix consists of 51.3% patients with basic insurance, 28.2% with semi-private insurance and 20.5% with private insurance. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.